NANZ POVIDONE- povinanz 7.5% ointment

Nanz Povidone by

Drug Labeling and Warnings

Nanz Povidone by is a Otc medication manufactured, distributed, or labeled by 1201258 Ontario Inc. O/A Nanz Pharma. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Purpose:

Topical Antifungal

Active Ingredients

7.5% Povidone Iodine Ointment USP, (0.75% available Iodine)

Uses:

For the treatment of athlete's foot, jock itch, and ringworm

For the effective relief of burning, cracking, discomfort, redness, scaling, soreness, and chafing that is associated with jock itch.

Warnings:

Do not use on children under 2 years of age unless directed by a doctor. For external use only. Avoid contact with the eyes. If irritation occurs or of there is no improvement within 4 weeks, discontinue use and consult a doctor. If irritation occurs or if there is no improvement within 2 weeks, discontinue use and consult a doctor.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. If swallowed, get medical help immediately or contact a Poison Control Center right away.

Inactive Ingredients:

POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400

Questions

Nanz Pharma

575 Granite Ct.

Pickering, ON

L1W 3K1

Directions

Apply a layer of the product over the affected area twice daily (morning and night) or as directed by a doctor. Supervise children in the use of this product. For athlete's foot: Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily. For athlete's foot and ringworm, use daily for 4 weeks; for jock itch, use daily for 2 weeks. If the condition persists longer, consult a doctor. This product is not effective on the scalp or nails.

To prevent athlete's foot, wash the feet and dry thoroughly. Apply a thin layer of the product to the feet once or twice daily (morning and/or night). Supervise children in the use of this product. Pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily.

Storage:

Store in dry and dark place at temperature not exceeding 30C

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

NANZ POVIDONE 
povinanz 7.5% ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 83254-750
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
POVIDONE-IODINE (UNII: 85H0HZU99M) (IODINE - UNII:9679TC07X4)	IODINE	7.5 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83254-750-50	150 g in 1 TUBE; Type 0: Not a Combination Product	05/04/2023
2	NDC: 83254-750-10	100 g in 1 TUBE; Type 0: Not a Combination Product	05/04/2023
3	NDC: 83254-750-90	90 g in 1 TUBE; Type 0: Not a Combination Product	05/04/2023
4	NDC: 83254-750-60	60 g in 1 TUBE; Type 0: Not a Combination Product	05/04/2023
5	NDC: 83254-750-30	30 g in 1 TUBE; Type 0: Not a Combination Product	05/04/2023
6	NDC: 83254-750-01	10 g in 1 TUBE; Type 0: Not a Combination Product	05/04/2023
7	NDC: 83254-750-15	15 g in 1 TUBE; Type 0: Not a Combination Product	05/04/2023
8	NDC: 83254-750-05	5 g in 1 TUBE; Type 0: Not a Combination Product	05/04/2023
9	NDC: 83254-750-31	1 g in 1 POUCH; Type 0: Not a Combination Product	05/04/2023
10	NDC: 83254-750-21	2 g in 1 POUCH; Type 0: Not a Combination Product	05/04/2023
11	NDC: 83254-750-55	5 g in 1 POUCH; Type 0: Not a Combination Product	05/04/2023

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	M005	05/04/2023

Labeler - 1201258 Ontario Inc. O/A Nanz Pharma (256906595)

Registrant - 1201258 Ontario Inc. O/A Nanz Pharma (256906595)

Establishment
Name	Address	ID/FEI	Business Operations
1201258 Ontario Inc. O/A Nanz Pharma		256906595	manufacture(83254-750) , pack(83254-750) , label(83254-750)